Carperitide in Acute Respiratory Distress Syndrome (ARDS)

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Carperitide is safe and effective in the management of Acute Respiratory Distress Syndrome (ARDS).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Suntory Pharmaceutical
• Treatments: Cardiodilatin

Criteria

Inclusion:

In order to participate in the study, patients must:

• be 18 years or older

• have an acceptable PF ratio

• have adequate fluid volume

• be intubated less than 7 days

Exclusion:

In order to participate in the study, patients must not meet any of the following criteria:

• be moribund

• be immunocompromised

• have pneumonia (caused by Pneumocystis carinii)

• have recieved another investigational drug or device within the last 30 days

• have a Do not Resuscitate order